Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation

NCT03994497 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT03994497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Unknown status
Start date
February 3, 2021
Completion date
February 2, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease